Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Motor Activity × pertuzumab × Breast × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 180 HER2-positive Breast Cancer 18 Neoplasm Metastasis 6 Inflammatory Breast Neoplasms 5 Triple Negative Breast Neoplasms 4 Neoplasms 4 Prostatic Neoplasms 3 Pathologic Complete Response 3 Pancreatic Neoplasms 3 HER2-positive Early Breast Cancer 3 Endometrial Neoplasms 3 Breast Neoplasms, Male 3 Anatomic Stage I Breast Cancer AJCC v8 3 Stomach Neoplasms 2 Ovarian Neoplasms 2 Multiple Myeloma 2 Locally Advanced Breast Cancer 2 Hematologic Neoplasms 2 HER2-positive Metastatic Breast Cancer 2 Gastrointestinal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Ductal, Breast 2 Breast Diseases 2 Brain Neoplasms 2 Anatomic Stage II Breast Cancer AJCC v8 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Thrombocytosis 1

Interventions

Exercise 71 Walking 9 Surveys and Questionnaires 8 Exercise Therapy 6 Diet 6 Resistance Training 5 High-Intensity Interval Training 5 Control Groups 4 methyl hydroxyethyl cellulose 3 Motivational Interviewing 3 Methods 3 Counseling 3 lime 2 Wearable Electronic Devices 2 Self-Management 2 Nutrition Assessment 2 Educational Status 2 Drug Therapy 2 Diet, Mediterranean 2 Creatine 2 Cognitive Behavioral Therapy 2 Behavior Therapy 2 Architectural Accessibility 2 pertuzumab 1 Whey Proteins 1 Trastuzumab 1 Therapeutics 1 Telemedicine 1 Somatotypes 1 Self-Help Groups 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06190600 2025-04-30

SPORTNATHy

The Greater Poland Cancer Centre

Phase NA Active not recruiting

Breast Neoplasms, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡